论文信息 - Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group - 字舞流文

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group

H. Dombret | S. Chevret | P. Chevallier | P. Fenaux | E. Deconinck | L. Adès | C. Gardin | S. de Botton | X. Thomas | C. Récher | N. Vey | O. Tournilhac | E. Raffoux | A. Pigneux | J. Lejeune | O. Spertini | J. Lambert | S. Girault | T. Marchand | Agnès Guerci Bresler